Today on in-pharmatechnologist.com   Genentech Avastin decision 'hard to overlook' Future of satraplatin uncertain GSK blocks new patent rules SCOLR on track for first 12-hour ibuprofen Inyx drama highlights crucial need for due diligence on contractors

Related Industry News   Clinical contract news in brief UK updates clinical trial negotiation system to include CROs Treating cancer as infectious disease yields results Parexel profits perky in Q1

Breaking News on Pharmaceutical Technology - Europe
Daily  Thursday 01 November 2007		Forward to a colleague

	Product Presentation Multi Channel Electronic Counter for Tablets and Capsules SWIFTPHARM takes electronic counting and bottle filling to higher levels of speed and accuracy and delivers twice the output of existing multi-track counters for a given footprint... Click Here Access Full Stories Genentech Avastin decision 'hard to overlook' Despite Genentech's recent decision to push out the cut-off date to ban the sale of cancer drug Avastin (bevacizumab) to compounding pharmacies in the US to restrict off-label use, ophthalmologists still find the... Read Future of satraplatin uncertain GPC Biotech has met another obstacle in its path towards satraplatin approval after the German company announced disappointing and unexpected results in its Phase III trial... Read GSK blocks new patent rules Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules... Read SCOLR on track for first 12-hour ibuprofen SCOLR Pharma has initiated the first of three pivotal trials to evaluate its extended release ibuprofen tablet, with hopes that it will be the first and only 12-hour formulation on the market... Read Inyx drama highlights crucial need for due diligence on contractors There are lessons to be learned about the importance of rigorous due diligence of pharma contractors, now that Inyx' customers are facing possible supply issues and a scramble to find alternative manufacturers... Read
	All News Headlines for: November | October | September
	Sponsored Message Supremely Flexible: Spray Drying from Niro The new PSD-1 pharmaceutical spray dryer from Niro allows you to perform exacting R&D as well as production of IMP's and small-scale manufacturing with one and the same unit. Drying with the PHARMASD series of spray dryers gives you optimum control of product properties... Click Here
	Related Industry News Clinical contract news in brief Outsourcing-Pharma.com compiles the news that featured in the clinical contract community this past week, involving PPD, Novotech and Generex... Read UK updates clinical trial negotiation system to include CROs An update to the contract negotiation system for hospital-based clinical trials has come into play in the UK - in a further effort to take some of the pain out of the process and speed up trial start-up times... Read Treating cancer as infectious disease yields results For the first time, scientists have found a way to target viral antigens deep inside a cancer tumour, and the result is a new therapy that could treat or even prevent the disease... Read Parexel profits perky in Q1 Parexel has seen its profits remain perky during its first financial quarter of 2008... Read Weekly Comment Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release. Read Sponsored Message LYCOAT™ for quicker quality coating Roquette has developed the LYCOAT™ range in response to market requirements for more functional coating solutions in terms of organoleptic properties, solubilisation and process efficiency... Click Here Previous Headlines Premature ejaculation spray coming to clinical climax A nifty spray-on solution could make all the difference for men plagued with the problem of climaxing too soon, as the product makes its final thrust in clinical development... Read Once-weekly diabetes treatment looking good A once-weekly Type II diabetes treatment has shown promise when compared to its twice-daily counterpart... Read Nycomed to acquire Bradley Nycomed is to acquire Bradley Pharmaceuticals for $346m (€240m) in a bid to make a niche for itself in the dermatology market... Read Pharmaceutical manufacturing: people on the move Pfizer, Savient Pharmaceuticals, Teva Pharmaceuticals, NPS Pharmaceuticals and MicroCHIPS have all had people on the move in the world of pharmaceutical manufacturing... Read Karma for big pharma? Sanofi-Aventis caught out by Inyx collapse Sanofi-Aventis has had to take Inyx USA to court after it failed to deliver on a contract manufacturing and supply agreement, a situation that Aventis feared could "seriously harm its interests". There may be important... Read Product Information - brochures, Web centers The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation Company Profile - Company Profile A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com